Shazi Shakil
Research areas: Medicine · Microbiology · Computational Drug Discovery Methods · Antibiotic Resistance in Bacteria · Cholinesterase and Neurodegenerative Diseases
0000-0003-4075-9153
About
Shazi Shakil, Ph.D.
Lecturer of Biology, Department of Biological Sciences, Purdue University Northwest, Hammond, IN, US
Work Authorization: U.S. Permanent Resident (No sponsorship required)
(former Professor, Institute of Genomic Medicine Sciences,
King Abdulaziz University, Jeddah, Saudi Arabia)
Email: [email protected]; [email protected]
Google Scholar: https://scholar.google.co.in/citations?user=gURcbbgAAAAJ&hl=en
Degrees: B.Sc.; M.Sc.; Ph.D.
Area of expertise-
Broad: Biotechnology, Microbiology, Drug Design.
Specific: Antibiotic design against ESBL-producing bacteria; CTX-M mediated antibiotic resistance in bacteria; Protein ligand docking.
Total experience: 15 years (post-Ph.D.)
Total number of publications: 109
Total Career Funding: approx. $1.7M+ in competitive research funding (as PI/Co-PI)
Mentored students: 17 (1 PhD, 4 master’s, 12 bachelor’s)
Google Scholar metrics: Citations, 7000+; h-index, 37; i10 index, 79
Verified International Academic Qualifications (Issued by World Education Services; for USA)
https://www.credly.com/badges/60ad0cf0-b7e1-4838-b8cd-d656f87f2344/public_url
BRIEF BIOGRAPHY
Dr. Shazi Shakil has a total number of scientific citations as over 7000 (Google Scholar). Total number of publications authored by Dr. Shazi is 109. He has an h-index of 37 and i10 index of 79 and has worked on many big and small projects. Dr. Shazi Shakil's broad research interests are Biotechnology, Microbiology and Drug Design. His thrust areas are Antibiotic design against ESBL-producing bacteria; CTX-M mediated antibiotic resistance in bacteria; and Protein-ligand-docking. He obtained his PhD in Biotechnology from Aligarh Muslim University (India) along with the “Most Active Research Scholar Award”. He has previously served at KFMRC, KAU, KSA and Integral University, India as Associate and Assistant Prof. He has served as editor and reviewer in several International indexed journals. He has guided dissertations of 1 Phd, 4 Masters and 12 Graduate students to completion. He is UGC-CSIR-NET, DBT-JRF, GATE (TWICE) qualified (98.3 percentile). He is a recipient of awards from various bodies like Bharat Vikas Parishad and CEPECAMI, India. Research thrust is on enzyme-ligand interaction-studies (bacterial antibiotic resistance enzymes etc). He coined the term ‘Enzoinformatics’. He has given the “Thumb Rule for Antibiotic Design” (https://pubmed.ncbi.nlm.nih.gov/36224195/).
Protein ligand docking
Profile WORLD RANK #1 on Google Scholar in the scientific field named "Protein ligand docking".
See this link:
https://scholar.google.com/citations?view_op=search_authors&hl=en&mauthors=label:protein_ligand_docking
ACADEMIC APPOINTMENTS
Lecturer of Biology
Purdue University Northwest, Hammond, IN, US | Aug 2026–present
Professor of Biotechnology (Microbiology & Drug Design)
King Abdulaziz University, Saudi Arabia | 2022–June 2026
Associate Professor
King Abdulaziz University | 2017–2022
Assistant Professor
King Abdulaziz University | 2015–2017
Assistant Professor
Integral University, India | 2012–2015
Assistant Professor
King Abdulaziz University | 2011–2012
Research Fellow (DBT Fellow)
Aligarh Muslim University, India | 2006–2010
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (107)
- Network Pharmacology-guided Identification of Therapeutic Targets and Pathways for Cancer Stem Cell Inhibition Across Multiple Cancer Types Save
- Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinase Save
- In depth molecular interaction analyses of the complex of a proposed CTXM-inhibitor bound to the bacterial enzyme Save
- Nano-Formulating Besifloxacin and Employing Quercetin as a Synergizer to Enhance the Potency of Besifloxacin against Pathogenic Bacterial Strains: A Nano-Synergistic Approach Save
- Molecular interaction of a putative inhibitor with bacterial SHV, an enzyme associated with antibiotic resistance Save
- Analysis of some flavonoids for inhibitory mechanism against cancer target phosphatidylinositol 3-kinase (PI3K) using computational tool Save
- Molecular interaction of anti-cancer ligands with human brain acetylcholinesterase Save
- Inflammation targeted nanomedicines: Patents and applications in cancer therapy Save
- In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer’s disease Save
- High Throughput Virtual Screening and Molecular Dynamics Simulation for Identifying a Putative Inhibitor of Bacterial CTX-M-15 Save
- Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer’s treatment Save
- Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management? Save
- Genotyping of interleukins-18 promoters and their correlation with coronary artery stenosis in Saudi population Save
- MOLECULAR INTERACTION OF INHIBITORS WITH HUMAN BRAIN BUTYRYLCHOLINESTERASE Save
- Association of autoimmunity and cancer: An emphasis on proteolytic enzymes Save
- Genomic and antimicrobial resistance genes diversity in multidrug-resistant CTX-M-positive isolates of Escherichia coli at a health care facility in Jeddah Save
- Identification of a putative anti-rheumatoid arthritis molecule by virtual screening Save
- Molecular interaction of 4-amino-N’-(benzoyloxy)-N-(2,4-dimethylphenyl)-1,2,5-oxadiazole-3-carboximidamide with the methotrexate binding site of human DHFR, and its implication in rheumatoid arthritis Save
- Molecular interaction of investigational ligands with human brain acetylcholinesterase Save
- Association of plasma fibrinogen level with insulin resistance in angiographically confirmed coronary artery disease patients Save